Immunomodulation of Bu-Zhong-Yi-Qi-Tang on in vitro granulocyte colony-stimulating-factor and tumor necrosis factor-α production by peripheral blood mononuclear cells

Immunopharmacology and Immunotoxicology

Volumn 22, Issue 4, 2000, Pages 711-720

  Kao, S T ^a   Yang, S L ^a   Hsieh, C C ^a   Yang, M D ^a   Wang, T F ^a   Lin, J G ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bu Zhong Yi Qi Tang; Granulocyte colony stimulating factor; Hepatocellular carcinoma; Tumor necrosis factor

Indexed keywords

BU ZHONG YI QI TANG; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CHINESE MEDICINE; CLINICAL ARTICLE; HERBAL MEDICINE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LIVER CELL CARCINOMA; MONONUCLEAR CELL; PLANT ROOT; PLANT SEED; PRIORITY JOURNAL;

EID: 0033679130     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923970009016434     Document Type: Article

References (27)

1. Mapping of chromosome 17 breakpoints in acute myeloid leukemias
2. G- and GM-CSF in oncology and oncological haematology
3. Cytokine enhancement of peripheral blood stem cells
4. An application of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in the case of hepatocellular carcinoma combined with liver cirrhosis in which leukopenia developed after chemoembolization
5. Coinbination immunotherapy with OK-432, recombinant granulocyte-colony-stimulating factor and recombinant interleukin-2 for human hepatocellular carcinoma
6. Regulation of the production and function of granulocytes and monocytes
7. Activation of the oxidative metabolism in human polymorphonuclear neutrophilic granulocytes: The role of immuno-modulating cytokines
8. Multifunctional cytokines in haemopoiesis
9. An endotoxin-induced serum factor that causes necrosis of tumors
10. Cachectin/tumour necrosis factor
11. Immune mechanisms in bacterial and parasitic diseases: Protective immunity versus pathology
12. Use of novel therapeutic agents for the treatment of serious infection
13. Tumour necrosis factors in immune regulation: Everything that's interesting is...new
14. Integrin regulation of an inflammatory effector gene. Direct induction of the tissue factor promoter by engagement of beta 1 or alpha 4 integrin chains
15. Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor
16. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-Ekki-To (TJ-41: Bu-Zhong-Yi-Qi-Tang)
17. Effect of a traditional Chinese Medicine, Bu-Zhong-Yi-Qi-Tang (Japanese name: Hochu-ekki-to) on the protection against Listeria monocytogenes infection on mice
18. Prophylactic anti-tumor effect of Hochu-ekki-to (TJ41) by enhancing natural killer cell activity
19. Nutritional parameters observed during 28-day infusion of recombinant human tumor necrosis factor-alpha
20. Natural killer and activated killer activites in chronic liver disease and hepatocellular carinoma: Evidence for a decreased lymphokine-induced activity of effector cells
21. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis
22. Antitumour effect of intratumoral injection of human recombinant interleukin-2 in patients with hepatocellular carcinoma: A preliminary report
23. Deficient natural killer cell activity in alcoholic cirrhosis
24. Abnormal natural killer cytotoxicity in primary biliary cirrhosis: Evidence for a functional deficiency of cytolytic effector cells
25. Tumor necrosis factors
26. Life-threatening toxicity of cancer therapy
27. Lymphokines and cytokines